Commercial Lidocaine Patch as a Treatment for Ear-ringing

Completed · Early Phase 1

Conditions studied: Tinnitus

In brief

The purpose of this investigation is to evaluate if topically applied lidocaine, in the form of lidocaine patches, reduces the burden of chronic subjective tinnitus in a consistent and measurable way.

Key facts

Study ID

NCT02088866

Run by

University of California, Davis

People needed

30

Starts

2014-03-01

Expected to finish

2015-09-01

Last updated by the study team

2017-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age
• History of chronic subjective tinnitus that cannot be attributed to vascular, neurologic, neoplastic or traumatic causes
• Capable of self-applying the lidocaine patches

You may not qualify if…

• History of heart disease
• History of irregular heartbeat
• Prior MI
• Previous exposure to lidocaine as a treatment for tinnitus
• An allergy to adhesives
• Allergy to lidocaine.
• Taking medications, herbal remedies and supplements that may interact with lidocaine, including but not limited to antivirals, benzodiazepines, and St. John's Wart
• Known liver disease
• Known kidney disease
• Adults who do not speak English,
• Adults who cannot consent for him or herself
• Women who are pregnant,
• Women who intend to become pregnant
• Nursing mothers
• Prisoners

Where it is running

• UC Davis Department of Otolaryngology — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.